Recursion Pharmaceuticals, Inc. (RXRX) Earnings
NASDAQ·Healthcare·Biotechnology
$3.69
-9.14%
Mkt Cap $2.12B
EPS — Estimate vs Actual
Mkt Cap
$2.12B
P/E
—
Fwd P/E
—
P/S
32.06
Rev TTM
—
EPS TTM
-$1.20
NASDAQ·Healthcare·Biotechnology
$3.69
-9.14%
Mkt Cap $2.12B
Mkt Cap
$2.12B
P/E
—
Fwd P/E
—
P/S
32.06
Rev TTM
—
EPS TTM
-$1.20